Over the fourth quarter of 2021, DM equities, except for Japan, were broadly positive, ending the third year in a row with strong calendar year returns, according to the latest UBP Quarterly Strategic Review & Outlook by Kier Boley, CIO of UBP’s Alternative Investment Solutions.
Over the fourth quarter of 2021, DM equities, except for Japan, were broadly positive, ending the third year in a row with strong calendar year returns, according to the latest UBP Quarterly Strategic Review & Outlook by Kier Boley, CIO of UBP’s Alternative Investment Solutions.
Boley writes: “EM equities suffered, mainly dragged down by higher inflation and negative news on China. On the fixed income side, uncertainties about future growth led to a flattening of the US yield curve. The front end of the curve moved higher, while the back end remained flat.
“Q4 provide to be a challenging quarter in terms of performance with losses concentrated in November resulting in the main alternatives index posting a small gain of +0.6 per cent, as measured by the HFRI Fund Weighted Composite Index. At the strategy level Equity Long Short and Event Driven posted the highest relative returns supporting their already strong outperformance through 2021. For the year it was notable the wide divergence in performance as equity focused strategies outperformed Discretionary Macro by over 10 percentage points.
“The emergence of the Omicron variant in November initially led to a strong increase in equity volatility. However, markets were quick to recover as initial data indicated a lower risk of severe disease. On the fixed income side, uncertainties about future growth due to less accommodative central bank policy led to a flattening of the US yield curve. This led the front end of the curve higher, while the back end remained flat across a number of DM markets.”
Newsletter
Like this article?
Sign up to our free newsletter
Q4 was a challenging quarter, says UBP AIS CIO
Related Topics
Over the fourth quarter of 2021, DM equities, except for Japan, were broadly positive, ending the third year in a row with strong calendar year returns, according to the latest UBP Quarterly Strategic Review & Outlook by Kier Boley, CIO of UBP’s Alternative Investment Solutions.
Over the fourth quarter of 2021, DM equities, except for Japan, were broadly positive, ending the third year in a row with strong calendar year returns, according to the latest UBP Quarterly Strategic Review & Outlook by Kier Boley, CIO of UBP’s Alternative Investment Solutions.
Boley writes: “EM equities suffered, mainly dragged down by higher inflation and negative news on China. On the fixed income side, uncertainties about future growth led to a flattening of the US yield curve. The front end of the curve moved higher, while the back end remained flat.
“Q4 provide to be a challenging quarter in terms of performance with losses concentrated in November resulting in the main alternatives index posting a small gain of +0.6 per cent, as measured by the HFRI Fund Weighted Composite Index. At the strategy level Equity Long Short and Event Driven posted the highest relative returns supporting their already strong outperformance through 2021. For the year it was notable the wide divergence in performance as equity focused strategies outperformed Discretionary Macro by over 10 percentage points.
“The emergence of the Omicron variant in November initially led to a strong increase in equity volatility. However, markets were quick to recover as initial data indicated a lower risk of severe disease. On the fixed income side, uncertainties about future growth due to less accommodative central bank policy led to a flattening of the US yield curve. This led the front end of the curve higher, while the back end remained flat across a number of DM markets.”
Like this article? Sign up to our free newsletter
Most Popular
Cboe to launch new Cboe S&P 500 Variance Futures
Biopharma hedge funds maintain momentum in August
Hedge funds up bets on yen rally
Zodia partners with Marinade to provide institutional clients access to Solana Staking
Multi-strat Arrowpoint expands Hong Kong office
Further Reading
Point72 to return billions in bid to cap assets
Elliott Advisors ups Director pay by 382% despite revenue dip
State Street launches fund to track hedge fund returns
Ex-Goldman Sachs MD back in banking after Citadel stint
KLS Scopia Market Neutral Equity Fund up 9.8% in year since UCITs launch
Elliott pressure prompts Southwest Airlines board overhaul
Founder leaves Brazil hedge fund Vinland Capital
ExodusPoint adopts cash hurdle
Featured
Point72 to return billions in bid to cap assets
ExodusPoint adopts cash hurdle
Hedge funds navigate record volatility to post August gains
Multi-manager hedge funds see outflows as investor interest wanes, says Goldman
New Hong Kong hedge fund secures support for bets on Japan market revival
Regal Partners eyes $1bn for new Cayman Islands fund
Goldman Sachs sells hedge fund stake for up to $258m amid valuation concerns
London hedge funds Kite Lake and Astaris to close to new investors